InterCloud Systems to Apply for Listing on OTC-QX
Aug 31, 2016 11:45 am UTC| Business
SHREWSBURY, N.J., Aug. 31, 2016 -- InterCloud Systems, Inc. (the “Company”) (NASDAQ:ICLD), a leading provider of cloud networking orchestration and automation solutions and services, today announced that rather than...
Ship Finance International Limited (NYSE: SFL) - Earnings Release
Aug 31, 2016 11:33 am UTC| Business
Hamilton, Bermuda, Aug. 31, 2016 -- Ship Finance International Limited ("Ship Finance" or the "Company") today announced its preliminary financial results for the quarter ended June 30, 2016. Highlights Declaration...
Aug 31, 2016 11:30 am UTC| Business
NEW YORK, Aug. 31, 2016 -- TG Therapeutics, Inc. (Nasdaq:TGTX), today announced that data from a Phase 1b open label study of TG-1101 (ublituximab) in acute relapses of neuromyelitis optica spectrum disorder (NMOSD),...
Amarin Randomizes Final Patient into REDUCE-IT Cardiovascular Outcomes Study of Vascepa
Aug 31, 2016 11:30 am UTC| Business
BEDMINSTER, N.J. and DUBLIN, Ireland, Aug. 31, 2016 -- Amarin Corporation plc (NASDAQ:AMRN) announced that randomization of patients into the REDUCE-IT cardiovascular outcomes study has been completed with 8,175...
Spark Therapeutics to Participate in Multiple September Conferences
Aug 31, 2016 11:30 am UTC| Business
PHILADELPHIA, Aug. 31, 2016 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company seeking to transform the lives of patients with debilitating genetic diseases by developing one-time,...
Aug 31, 2016 11:30 am UTC| Business
CRANBURY, N.J., Aug. 31, 2016 -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of rare and orphan diseases, today announced that 7 posters highlighting its Fabry program will be...
MacroGenics to Participate in Two Upcoming Investor Conferences
Aug 31, 2016 11:30 am UTC| Business
Rockville, MD, Aug. 31, 2016 -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the...